Search Results - "Eteläinen, Tony"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
  2. 2

    Removal of proteinase K resistant αSyn species does not correlate with cell survival in a virus vector-based Parkinson's disease mouse model by Eteläinen, Tony S., Kilpeläinen, Tommi P., Ignatius, Adele, Auno, Samuli, De Lorenzo, Francesca, Uhari-Väänänen, Johanna K., Julku, Ulrika H., Myöhänen, Timo T.

    Published in Neuropharmacology (01-11-2022)
    “…Parkinson's disease (PD) is characterized by degeneration of nigrostriatal dopaminergic neurons and accumulation of α-synuclein (αSyn) as Lewy bodies…”
    Get full text
    Journal Article
  3. 3

    Repeated Ethanol Exposure Alters DNA Methylation Status and Dynorphin/Kappa-Opioid Receptor Expression in Nucleus Accumbens of Alcohol-Preferring AA Rats by Niinep, Kerly, Anier, Kaili, Eteläinen, Tony, Piepponen, Petteri, Kalda, Anti

    Published in Frontiers in genetics (24-11-2021)
    “…Growing evidence suggests that epigenetic mechanisms, such as DNA methylation and demethylation, and histone modifications, are involved in the development of…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Tetrazole as a Replacement of the Electrophilic Group in Characteristic Prolyl Oligopeptidase Inhibitors by Kilpeläinen, Tommi P, Tyni, Jonna K, Lahtela-Kakkonen, Maija K, Eteläinen, Tony S, Myöhänen, Timo T, Wallén, Erik A. A

    Published in ACS medicinal chemistry letters (12-12-2019)
    “…4-Phenylbutanoyl-aminoacyl-2­(S)-tetrazolylpyrrolidines were studied as prolyl oligopeptidase inhibitors. The compounds were more potent than expected from the…”
    Get full text
    Journal Article
  6. 6

    The selective κ-opioid receptor antagonist JDTic attenuates the alcohol deprivation effect in rats by Uhari-Väänänen, Johanna, Eteläinen, Tony, Bäckström, Pia, Oinio, Ville, Carroll, F. Ivy, Raasmaja, Atso, Kiianmaa, Kalervo, Piepponen, Petteri

    Published in European neuropsychopharmacology (01-12-2019)
    “…•Systemic and intra-accumbens shell JDTic, a κ-antagonist, attenuated the ADE in rats.•A low dose of naltrexone inhibited the ADE and decreased ethanol…”
    Get full text
    Journal Article
  7. 7

    Novel Small‐Molecular Ligands for Prolyl Oligopeptidase to Combat Tauopathies by Eteläinen, Tony, Pätsi, Henri, Uhari‐Väänänen, Johanna, Aikkila, Hannes, Cui, Hengjing, De Lorenzo, Francesca, Kilpeläinen, Tommi, Julku, Ulrika, Wallén, Erik A.A., Myöhänen, Timo T

    Published in Alzheimer's & dementia (01-12-2023)
    “…Background Tauopathies that include e.g. frontotemporal dementia and Alzheimer’s disease, are neurodegenerative diseases characterized by accumulation of…”
    Get full text
    Journal Article